摘要
目的:探讨中医药在肝癌的中西医结合治疗中所发挥的作用。方法:通过癌株传代法建立H_(22)肝癌小鼠模型,将造模成功的40只肝癌小鼠随机分为模型组、消癥软肝方组、5-氟尿嘧啶组以及消癥软肝方联合5-氟尿嘧啶组。中药组以消癥软肝方配方颗粒0.2 mL/d剂量灌胃治疗,西药组以5-氟尿嘧啶20 mg/kg·d^(-1)腹腔注射治疗,联合用药组给予中西药物联合治疗,连续给药12 d。结果:联合用药组小鼠的脾指数、胸腺指数明显好于西药组,抑瘤率和血管内皮生长因子(VEGF)、基质金属蛋白酶9(MMP-9)蛋白的表达都明显优于中药组和西药组。结论:消癥软肝方具有明显的抗癌作用,能够增强5-氟尿嘧啶的抗癌效果,其作用机制与抑制肿瘤血管生成有关。
Objective: to explore the effect of Chinese medicine in treating hepatocarcinoma with combined therapy of TCM and western medicine.Methods: 40 H22 hepatocarcinoma model mice, made by cancer strain passage method, were randomly divided into model group, Chinese medicine group (administrated with Xiaozheng Ruangan formula granules by 0.2 mL/d), western medicine group (injected with 5-fluorouracil by 20 mg/kg·d-1), and combination group.The administration lasted for 12 days.Results: spleen index and thymus gland index of combination group were obviously higher than that of western medicine group;inhibition rate, vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) expressions were superior to that of Chinese and western medicine groups.Conclusion:Xiaozheng Ruangan Formula has obvious anticancer effect and can enhance the antitumor effect of 5-fluorouracil, and its mechanism is related to the inhibition of tumor angiogenesis.
出处
《河北中医药学报》
2017年第4期1-3,11,共4页
Journal of Hebei Traditional Chinese Medicine and Pharmacology
基金
河北省中医药管理局资助项目:No.2016037
关键词
原发性肝癌
消癥软肝方
5-氟尿嘧啶
化浊解毒固本
疏肝柔肝
VEGF
MMP-9
VEGF
primary hepatocarcinoma
Xiaozheng Ruangan Formula
5-fluorouracil
resolving turbidity
removing toxin and consolidating foundation
soothing liver and nourishing liver
VEGF